Baxter's Q4 beats street on hemophilia therapies; Valeant plots $1.5B note-and-stock buyback; Teva to sell MDxHealth tests in Israel;

@FiercePharma: Biotechs trumpet pandemic vaccine deals and data as the H7N9 bird flu threat grows. Story from FierceVaccines | Follow @FiercePharma

@TracyStaton: Two top stories at FiercePharma yesterday are both RE Novartis job cuts. Swiss, with rehires (Story) and New York, with Novartis plant closing by 2017 (Story) | Follow @TracyStaton

@EricPFierce: Closing of U.S. Lonza plant took a toll on its sales last quarter as expiring contracts were not renewed. Story from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: We're taking nominations for the 25 most influential people in biopharma for our annual report. Submit them here. Survey | Follow @CarlyHFierce

> Baxter's ($BAX) fourth-quarter profits topped analyst estimates, thanks to heightened demand for its hemophilia treatments. Report

> Valeant Pharmaceuticals ($VRX) said it may buy back as much as $1.5 billion worth of its notes and shares. Report

> Teva Pharmaceutical Industries ($TEVA) inked a deal with MDxHealth to commercial its cancer diagnostic tests in Israel. Report

> Goldman Sachs said it had placed a 5% stake in Spain's Almirall; sold by Grupo Plafin, the stake sold at €11.75 per share, or €102 million ($138 million). Report

> India's Biocon saw its shares slump today after reporting earnings that fell short of some expectations. Report

Medical Device News

@FierceMedDev: In 2013, eNeura won de novo approval in the U.S. for its anti-migraine device. Report | Follow @FierceMedDev

@MarkHFierce: Stryker grew net sales by 5.6% in Q4. Release | Follow @MarkHFierce

@MichaelGFierce: Statins delivered with HDL nanoparticles reduce risk of second heart attack, stroke. Story from FierceDrugDelivery | Follow @MichaelGFierce

@EmilyWFierce: Quest Diagnostics inks $570M Solstas deal. Story | Follow @EmilyWFierce

> Covidien opens an Indian medical training center with a med tech focus. Article

> Varian touts emerging markets as looming Medicare changes take a toll. News

> Quest Diagnostics will pay $570M for another laboratory testing outfit. Item

> For Stryker, acquisitions began to generate financial benefits in late 2013. More

> Medtronic wins patent loss reversal in U.S. Supreme Court. Report

Biotech News

@FierceBiotech: U.K. to digitize patient health records and sell access to biopharma researchers. Story from FierceBiotech IT | Follow @FierceBiotech

@JohnCFierce: U.K. group looks to ignite a Boston-style biotech comeback. More | Follow @JohnCFierce

@DamianFierce: Reminder that FierceBiotech's annual list of the most influential people in biopharma is now (somewhat) democratic. More | Follow @DamianFierce

@EmilyMFierce: This map of vaccine-preventable diseases is pretty striking. Map | Follow @EmilyMFierce

> Can Roche's old R&D campus attract biotechs? Item

> Amgen notches another PhIII win for its PCSK9 blockbuster hopeful. News

> Pfizer's pain med clears PhIII as long-delayed Remoxy waits in the wings. Report

> J&J carves out a new group to develop drugs for poor countries. Article

> Buzz: Back from the ER, a wounded Ariad spurs a fresh round of takeover rumors. More

Pharma Manufacturing News

> J&J consumer health boosts results, even without key plant. Story

> Par bolsters its sterile manufacturing with a $490M deal to grab JHP. Story

> New York plant that makes Diovan is next on Novartis' shutdown list. Story

> Glaxo is investing $200M in additions to its U.K. site. Story

> Lilly gets ready for track-and-trace in U.S. Item

> Lonza's pharma unit sales suffer as it closes U.S. biologics plant. Article

Vaccines News

> How vaccines helped India defeat polio while Pakistan became a reservoir for the virus. Story

> Study: Tightening vaccine exemption laws would cut cases of whooping cough. Story

> Map of vaccine-preventable diseases shows the scale of problems facing the West. Story

> Biotechs trumpet pandemic vaccine deals and data as the H7N9 bird flu threat grows. Story

> NIH backs New York MERS-CoV vaccine development program. Story

> The political causes of the Syrian polio crisis. Item

And Finally... Fish oil may help preserve brain cells, a study found. Report

Suggested Articles

After Trump's "Buy American" executive order for essential medicines, the pharma industry is pushing back.

The U.S. is slamming the brakes on its $765 million loan to Kodak amid insider trading allegations and questions about its fitness for the job.

When it comes to COVID-19 vaccines and treatments, more news is good news. That’s the latest takeaway from consumer sentiment tracking by Harris Poll.